AGL agilon health inc

  1. Stocks
  2. Healthcare
  3. NYSE: AGL

Price (delayed)

$97.68

Market cap

$1.63B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$21.55

Enterprise value

$1.45B

?
Relative Growth: Rel. Growth: 40
Relative Strength: Rel. Strength: 99
Relative Valuation: Rel. Valuation: 41
Relative Profitability: Rel. Profitability: 5

agilon health is transforming healthcare by empowering community-based physicians with the resources and expertise they need to innovate the payment and delivery of care for seniors. agilon health enables physicians ...

Highlights
The debt has contracted by 14% from the previous quarter and by 14% YoY
The company's gross profit rose by 9% QoQ
The equity has shrunk by 64% YoY but it has increased by 43% QoQ
The EPS has declined by 50% year-on-year but it is up by 9% since the previous quarter
The company's revenue fell by 2.8% YoY
Sector: Healthcare
Industry: Medical Care Facilities
Website: http://www.agilonhealth.com
Peers: TOI

Key stats

What are the main financial stats of AGL

AGL stock price

How has the agilon health stock price performed over time
Intraday
18.11%
1 week
8.09%
1 month
262.58%
1 year
78.41%
YTD
467.25%
QTD
1,134.89%

Financial performance

How have agilon health's revenue and profit performed over time
Revenue
$5.82B
Gross profit
-$145.73M
Operating income
-$437.13M
Net income
-$354.54M
Gross margin
-2.5%
Net margin
-6.1%
The net margin has plunged by 53% YoY but it has grown by 8% from the previous quarter
The net income has contracted by 47% YoY but it has grown by 9% from the previous quarter
agilon health's operating margin has decreased by 47% YoY but it has increased by 3.8% QoQ
The operating income has contracted by 42% YoY but it has grown by 6% from the previous quarter

Price vs fundamentals

How does AGL's price correlate with its fundamentals

Growth

What is agilon health's growth rate over time

Valuation

What is agilon health stock price valuation
P/E
N/A
P/B
8.93
P/S
0.28
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.25
The EPS has declined by 50% year-on-year but it is up by 9% since the previous quarter
The equity has shrunk by 64% YoY but it has increased by 43% QoQ
The stock's P/B is 26% more than its 5-year quarterly average of 6.0
AGL's P/S is 140% above its last 4 quarters average of 0.1 but 91% below its 5-year quarterly average of 2.6
The company's revenue fell by 2.8% YoY

Efficiency

How efficient is agilon health business performance
AGL's return on invested capital has dropped by 91% since the previous quarter
The ROA has dropped by 91% year-on-year but it is up by 2.9% since the previous quarter
The return on sales has dropped by 54% year-on-year but it is up by 8% since the previous quarter
The ROE fell by 19% QoQ

Dividends

What is AGL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AGL.

Financial health

How did agilon health financials performed over time
agilon health's total assets is 14% more than its total liabilities
agilon health's total assets has decreased by 22% YoY but it has increased by 18% from the previous quarter
The quick ratio has declined by 19% year-on-year but it is up by 7% since the previous quarter
The debt is 83% less than the equity
The company's debt to equity has surged by 143% YoY but it fell by 39% QoQ
The equity has shrunk by 64% YoY but it has increased by 43% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.